Alzheimer's Research & Therapy
Eighteen-month real-world outcomes of lecanemab treatment and transition to maintenance therapy in early Alzheimer’s disease
Study in peopleInterventions
Papers by Aya Bar-David
2 results
- AAIC 2025 Abstract
Lecanemab in Practice: Real‐World Data from a 6‐Month Follow‐Up in Early Alzheimer’s Disease
Trial in peopleInterventions